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Abstract
Background: Previously, several indexes based on a large number of clinical and laboratory tests to predict
mortality and frailty have been produced. However, there is still a need for an easily applicable screening tool for
every-day clinical practice.
Methods: A prospective study with 10- and 18-year follow-ups. Fourteen common laboratory tests were combined
to an index. Cox regression model was used to analyse the association of the laboratory index with
institutionalization and mortality.
Results: The mean age of the participants (n = 1153) was 73.6 (SD 6.8, range 64.0–100.0) years. Altogether, 151
(14.8%) and 305 (29.9%) subjects were institutionalized and 422 (36.6%) and 806 (69.9%) subjects deceased during
the 10- and 18-year follow-ups, respectively. Higher LI (laboratory index) scores predicted increased mortality.
Mortality rates increased as LI scores increased both in unadjusted and in age- and gender-adjusted models during
both follow-ups. The LI did not significantly predict institutionalization either during the 10- or 18-year follow-ups.
Conclusions: A practical index based on routine laboratory tests can be used to predict mortality among older
people. An LI could be automatically counted from routine laboratory results and thus an easily applicable
screening instrument in clinical settings.
Keywords: Laboratory index, Institutionalization, Mortality, Aged
Background
Frailty is a syndrome defined as a loss of resources in sev-
eral domains leading to increased vulnerability to stressors
[1–4]. Frailty predicts adverse outcomes such as increased
falls, hospitalization, morbidity, dependence, and mortality
[2, 3, 5]. Symptoms, signs, diseases, disabilities, medica-
tions, or laboratory measurements can be combined in an
index to measure frailty [1, 6–8], which is calculated as
the proportion of individual’s deficits in relation to the
total amount of deficits chosen [1, 9–14]. Frailty indexes
(FI) are strongly associated with the risk of death,
institutionalization, and worsening health status, especially
when at least 30 variables are included although different
FIs consider different deficits [1, 13, 15, 16]. FIs show a
consistent, sub-maximal limit at about 2/3 of the deficits
that are considered [1, 17–19].
Earlier studies have demonstrated that prediction of
mortality and other adverse health outcomes can also be
based on laboratory data [8, 14, 17, 18, 20, 21]. Many
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factors, such as various diseases, characterized by in-
creased frequency in the elderly, influence blood-derived
biochemical values [22]. The impact of these factors may
differ in the elderly compared with younger age groups
[22]. Howlett et al. [20] demonstrated that a laboratory
data -based index can be used to identify older adults at
increased risk of death. In their study, a laboratory-based
index and a clinical FI were both independently associ-
ated with mortality. In a study with older adults in long-
term care facilities, Rockwood et al. [18] found a strong
linear relationship with a laboratory-based index and a
clinical FI. A laboratory-based index could identify long
term care residents at increased risk of death. Blodgett
et al. [14] examined associations of a laboratory-based
index and adverse health outcomes in adult population
and found that higher index scores were associated with
poor health outcomes at all ages. In their study, there
was a weak correlation between a laboratory-based index
and a clinical FI. They suggested that a laboratory-based
index could be utilized as an early screening tool to
identify deficit accumulation at the cellular and molecu-
lar level before they become clinically visible [14, 21].
Subclinical deficits, taken together, even including defi-
cits not individually related to death, have been shown
to be related to adverse outcomes of aging and precede
clinically evident health deficits [18–21, 23]. A
laboratory-based index has also been studied in acutely
ill older adults admitted to hospital and could be useful
also in an acute setting [24–26].
We have earlier demonstrated that clinical frailty tools
are applicable screening instruments among Finnish
community-dwelling older people [15, 16]. Frailty was
associated with higher mortality according to three dif-
ferent clinical frailty screening tools. Simple and fast
clinical frailty tools were found comparable with a multi-
dimensional and time-consuming FI [15].
The aim of this study was to analyse whether a labora-
tory index based on 14 commonly used laboratory tests
can be used to evaluate the risk of institutionalization
and mortality among Finnish older people during 10-
and 18-year follow-ups.
Methods
Study design and population
This study is part of a longitudinal epidemiological study
carried out in the municipality of Lieto in south-western
Finland [27]. All persons born in or prior to the year
1933 (n = 1596) were invited to participate in the base-
line examination which was carried out between March
1998 and September 1999. Of those eligible, 63 died be-
fore they were examined, and 273 refused or did not re-
spond, leaving 1260 (82%) participants, 533 men and
727 women. They were followed-up for
institutionalization and mortality for 18 years.
Participants no longer living in Lieto at the end of
2016 (n = 86) were excluded from the present analyses
predicting institutionalization, as it was not possible to
ascertain whether they were institutionalized in their
current municipality or whether they lived at home.
Sixty-eight participants were already living in institu-
tional care at the start of the study and were excluded
from the institutionalization analyses. Also, participants
with missing data of analytes needed for the laboratory
index (n = 107) were excluded leaving 1019 and 1153
participants for the final study cohort predicting
institutionalization and mortality, respectively.
Measurements
Venous blood samples were obtained with minimal sta-
sis between 8 and 10 am after overnight fast at Lieto
Health Center. Fresh samples were analyzed at the Cen-
tral laboratory of Turku University hospital. All partici-
pants were given verbal and written instructions on
preparing for the blood sample collection before labora-
tory visit.
Mortality
Data from all participants who died before January 2017
were obtained from the Statistics of Finland Causes of
Death -registry identified with unique personal identifi-
cation numbers.
Institutionalization
Institutionalization was defined as permanent entry into
a nursing home of which the data were gathered from
the municipality’s electronic patient record system and
coded by month and year of entry.
Laboratory index
In this study we created a laboratory index (LI) compris-
ing fourteen laboratory analytes. The laboratory analytes
that constitute the LI and their reference ranges or cut-
off values are shown in Table 1. The index is calculated
as the proportion of individual’s laboratory test results
outside reference ranges in relation to the total amount
of analytes tested. In selecting the analytes that construct
the LI we included routine laboratory parameters that
are readily available, and thus easy to test from all eld-
erly patients also in primary health care.
The index was constructed by coding each analyte as
either 0 or 1; 0 indicates that the value was within the
normal range or cutoff and 1 that the value was above
or below the normal range or cut-off. The sum of these
values was then divided by the total number of the ana-
lytes resulting in a score ranging from 0 to 1 for each
individual.
To compare the adverse outcomes of individuals with
different LI scores, we divided the participants in five
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categories (1. LI ≤0.08 [≤ 1 laboratory test result outside
reference ranges], 2. LI 0.09–0.14 [2 laboratory test re-
sults outside reference ranges], 3. LI 0.15–0.21 [3 labora-
tory test results outside reference ranges], 4. LI 0.22–
0.42 [4 to 5 laboratory test results outside reference
ranges], and 5. LI ≥0.43 [≥6 laboratory test results out-
side reference ranges]). The division in five categories is
similar to other studies on laboratory-based indexes.
Statistical analyses
Hazard ratios (HRs) and their 95% confidence intervals
for all-cause mortality and institutionalization were cal-
culated using Cox proportional hazard models. Propor-
tional hazards assumption was tested using Martingale
residuals. The follow-up periods were calculated from
the baseline measurements to the end of the follow-up
period of 10 and 18 years or to the death of the individ-
ual. Death was used as a competitive factor in the
analyses for institutionalization. Both unadjusted and
age- and gender-adjusted analyses were conducted. P
values less than 0.05 were considered statistically signifi-
cant. All statistical analyzes were performed using SAS




The mean age of the participants was 73.6 years (range
64–100 years). The majority (58%) of the participants
were women. More detailed baseline characteristics of
1153 study participants are shown in Table 2.
Laboratory index in predicting mortality
Altogether, 422 (36.6%) and 806 (69.9%) subjects de-
ceased during the 10- and 18-year follow-ups,
respectively.
Higher LI predicted increased mortality. Index scores
of 0.09 or over and 0.15 or over, predicted increased
mortality during the 10- and 18-year follow-ups, respect-
ively. These associations also persisted after adjustments
for age and gender. Figure 1 shows Kaplan-Meier sur-
vival curves by the categories of LI (Tables 3 and 4).
Laboratory index in predicting institutionalization
Altogether, 151 (14.8%) and 305 (29.9%) subjects were
institutionalized during the 10- and 18-year follow-ups,
respectively. The LI did not significantly predict
institutionalization during either of the follow-ups in un-
adjusted or age- and gender-adjusted models (data not
shown).
Discussion
Our results suggest that an index based on fourteen rou-
tine laboratory analytes can be used to predict mortality
in an elderly population. The LI was significantly associ-
ated with mortality but not with institutionalization
Table 1 Reference ranges used for the analytes in laboratory
indices for men and women
Men Women
Hemoglobin (g/L) 128–168 117–153
Albumin (g/L) 36.1–47.5 34.8–46.1
Calcium (mmol/L) 2.17–2.47 2.17–2.47
Urate (μmol/L) 180–420 130–340
TSH (mU/L) 0.4–4.5 0.4–4.5
Creatinine (μmol/L) < 135 < 125
Ferritin (μg/L) 20–240 10–100
CRP (mg/L) < 3 < 3
Sodium (mmol/l) 136–144 136–144
Potassium (mmol/L) 3.5–4.8 3.5–4.8
Glucose (mmol/L) 4.0–6.4 4.0–6.4
ALT (U/L) < 50 < 35
ALP (U/L) < 300 < 300
LDL cholesterol (mmol/L) < 3.5 < 3.5
Abbreviations: TSH thyroid stimulating hormone, CRP C-reactive protein, ALT
alanine aminotransferase, ALP alkaline phosphatase, LDL
low-density lipoprotein
Table 2 Baseline characteristics of study participants (n = 1153)
n (%)




≥ 85 99 (9)
Women 663 (58)
Living alone 344 (30)
Education
More than basica or basic 103 (9)
Less than basic 1050 (91)
MMSE ≤26 323 (28)
Body mass index, kg/m2




≥ 35 61 (5)
Number of prescribed medicines
< 5 855 (74)
5–7 207 (18)
8–9 66 (6)
≥ 10 25 (2)
aSix years of elementary school
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during the 10- and 18-year follow-ups. The association
of the LI with mortality remained after adjustments for
age and gender.
We included fourteen routinely tested laboratory ana-
lytes in our index which is a fairly small number of pa-
rameters compared to prior studies on laboratory-based
indexes [8, 17, 18, 20]. A laboratory index based on
smaller number of parameters could be easily applied in
use in any hospital or health center. In many countries,
laboratory information systems could automatically cal-
culate the LI. In prior studies with more analytes se-
lected in a laboratory index, some analytes reflect the
health status of the same or partly the same organ sys-
tem such as hemoglobin, red blood cells, mean corpus-
cular volume and hematocrit (hematopoiesis), or alanine
aminotransferase, aspartate alanine transferase and
gamma-glutamyl transferase (the liver) [17, 20]. In
selecting the analytes that construct the LI, care was
taken that the information obtained from the analytes
did not overlap significantly but captured information
with respect to health status of different organ systems.
The LI did not predict institutionalization which
seems to be better predicted with clinical FIs [1, 16].
Routine laboratory parameters do not predict dementia
or cognitive impairment which are considered the most
common causes for institutionalization [28–32]. Other
predictive factors for institutionalization, impairing an
older person’s ability to live independently, are increased
falls, decreasing body mass index [28, 29] and functional
impairment and disabilities, especially when combined
with cognitive impairment [30–32].
The strengths of our study are the large sample size,
good participation rate of 82% and a long follow-up
period that enable broad generalizability of the results.
The data comes from a community-based representative
sample of the Finnish population. The gender distribu-
tion of the participants is comparable to the distribution
of this age group in the whole country [33], and the
prevalence of cognitive impairment is similar to the esti-
mated prevalence in the whole country [34].
A limitation to our study is that the LI has not yet
been validated by means of an independent study popu-
lation or compared to a clinical index. Further research
on the validation of the LI is needed.
In clinical settings, the construction of an index using
available routine laboratory data may be easier and more
harmonized than using data based on clinical assess-
ment. Finding those individuals at an increased risk of
death could help clinicians in targeting those patients
that need medical interventions. Many of the risk factors
that can be identified by laboratory tests, can be treated,
when found early enough. As using this laboratory index
would not be time-consuming or expensive, it could
Table 3 Hazard ratios (HR) and their 95% confidence intervals (CI) (in parentheses) of laboratory index (LI) for mortality during the
10-year follow-up
Total n Deceased n
(%)
Unadjusted HR (95% CI) P-value Adjusteda HR (95% CI) P-value
LI
≤ 0.08b 383 92 (24) 1
0.09–0.14c 326 119 (36) 1.61 (1.23–2.12) < 0.001 1.69 (1.28–2.22) < 0.001
0.15–0.21d 211 87 (41) 1.96 (1.46–2.63) < 0.001 1.84 (1.37–2.48) < 0.001
0.22–0.42e 190 93 (49) 2.46 (1.84–3.28) < 0.001 2.20 (1.64–2.94) < 0.001
≥ 0.43f 43 31 (72) 5.56 (3.71–8.40) < 0.001 3.75 (2.46–5.72) < 0.001
Total 1153 422 (37)
aValues are adjusted for age and gender






Fig. 1 Survival curves by laboratory index (LI) comprising 14
commonly used laboratory tests during the 18-year follow-up. The
number of laboratory tests outside reference ranges by categories of
LI: 0–0.08≤ 1; 0.09–0.14 = 2; 0.15–0.21 = 3; 0.22–0.42 = 4–5; 0.43– ≥ 6
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serve as an alert for the clinician to pay attention to
those patients with a high index score. Some studies
have found strong and some weak correlations between
clinical FIs and laboratory indexes [17, 18, 20, 21, 35].
They seem to be distinct entities although both can be
used to predict mortality. Laboratory indexes may find
deficits at cellular, molecular or organ level prior to clin-
ical deficits [21]. Previously, there have been some stud-
ies that have used both clinical and laboratory data to
construct a combined FI, which might assess frailty more
accurately [17, 18, 20, 21]. The combination of labora-
tory and clinical data to construct a frailty index would
be an interesting further study also in Finnish elderly
population cohort.
Conclusions
Findings of our study suggest that a practical index
based on 14 routine laboratory tests can be used to pre-
dict mortality among older people. The number of rou-
tine laboratory test results outside reference ranges
correlates with older people’s mortality. An LI could be
an easily applicable screening instrument in clinical
settings.
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